Nagpur, Maharashtra, India
+919730867604
 Nagpur, Maharashtra, India
+919730867604
+917218129896

Dutahreal 0.5 mg (Dutasteride) Export from India to USA, UK, Canada, Australia, New Zealand, UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Bangladesh, Nepal, Sri Lanka, South Africa, Nigeria, Kenya, Ghana, Tanzania, Uganda, Egypt, Morocco, Algeria, Brazil, Mexico, Colombia, Chile, Peru, Argentina, Germany, France, Spain, Portugal, Netherlands, Belgium, Switzerland, Austria, Sweden, Norway, Denmark, Finland, Poland, Romania, Greece, Turkey and Worldwide Markets

Dutahreal 0.5 mg contains Dutasteride 0.5 mg, a prescription medicine belonging to the 5-alpha-reductase inhibitor class. It is commonly prescribed for the management of benign prostatic hyperplasia (BPH) and related urinary symptoms associated with an enlarged prostate.

MEDINDIA EXPORT supplies pharmaceutical products from India to international markets, subject to applicable prescription, import, registration, and regulatory requirements.

Dutahreal 0.5 mg Composition

  • Product: Dutahreal 0.5 mg
  • Active Ingredient: Dutasteride 0.5 mg
  • Dosage Form: Capsule
  • Therapeutic Category: Urology / BPH treatment
  • Drug Class: 5-alpha-reductase inhibitor
  • Prescription: Prescription medicine

Uses of Dutahreal 0.5 mg

Dutahreal 0.5 mg is prescribed by healthcare professionals for conditions such as:

  • Benign prostatic hyperplasia (BPH)
  • Enlarged prostate
  • Improvement of urinary symptoms associated with BPH
  • Reduction of the risk of acute urinary retention in appropriate BPH patients

Dutasteride works by reducing the conversion of testosterone to dihydrotestosterone (DHT), which can help reduce prostate enlargement over time.

Dutahreal 0.5 mg Export from India

India is an important global source of pharmaceutical products, offering a broad manufacturing and supply network. MEDINDIA EXPORT supports international pharmaceutical buyers seeking Dutahreal 0.5 mg from India, with supply arrangements depending on destination-country regulations and product availability.

Potential international markets include:

USA, Canada, United Kingdom, Ireland, Australia, New Zealand, UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Bangladesh, Nepal, Sri Lanka, South Africa, Nigeria, Kenya, Ghana, Tanzania, Uganda, Egypt, Morocco, Algeria, Brazil, Mexico, Colombia, Chile, Peru, Ecuador, Argentina, Germany, France, Italy, Spain, Portugal, Netherlands, Belgium, Switzerland, Austria, Sweden, Norway, Denmark, Finland, Poland, Romania, Greece, Turkey and other eligible international markets.

Importers should verify local registration, prescription, customs, labeling, and import requirements before placing an order.

Why Source Dutahreal 0.5 mg from India?

International pharmaceutical buyers may consider Indian suppliers because of:

  • Competitive pharmaceutical sourcing
  • Established manufacturing infrastructure
  • Wide range of generic medicines
  • Export-oriented pharmaceutical supply chains
  • International logistics support
  • Availability of documentation according to applicable requirements

Dutahreal 0.5 mg Trading & Export FAQs

1. What is Dutahreal 0.5 mg?

Dutahreal 0.5 mg is a prescription medicine containing dutasteride 0.5 mg, primarily used for the treatment of benign prostatic hyperplasia.

2. What is the active ingredient?

The active pharmaceutical ingredient is Dutasteride 0.5 mg.

3. Is Dutahreal 0.5 mg a prescription medicine?

Yes. Dutasteride is generally a prescription medicine and should be used under medical supervision.

4. Can Dutahreal 0.5 mg be exported from India?

Export availability depends on applicable Indian export rules, destination-country regulations, product documentation, and importer requirements.

5. Which countries can import Dutahreal 0.5 mg?

Supply may be possible to eligible international markets, subject to the laws and pharmaceutical import requirements of the destination country.

6. Can I order Dutahreal 0.5 mg for pharmaceutical distribution?

International distributors and licensed pharmaceutical buyers can contact MEDINDIA EXPORT to discuss availability, documentation, quantities, and destination requirements.

7. What documents may be required for pharmaceutical export?

Depending on the shipment and destination, documentation may include commercial invoices, packing lists, shipping documents, product-related documents, and other certificates or permits required by the importing country.

8. How can I request a quotation?

International buyers can contact MEDINDIA EXPORT by email or WhatsApp with the required quantity, destination country, and product specifications.

International Pharmaceutical Supply

MEDINDIA EXPORT works with international buyers seeking pharmaceutical products sourced from India. Product availability, minimum order quantities, pricing, shipping methods, and documentation can vary according to the destination and applicable regulations.

For Dutahreal 0.5 mg export inquiries:

🌐 Website: www.medicineindiaexport.com
📧 Email: sales.medindiaexport@gmail.com
📱 WhatsApp: +91 7218129896

 2026-09-08T07:15:23

Other Pages

View all pages
Pantodice DSR Export from India | Pantoprazole & Domperidone Capsules for Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Canada, Central African Republic, Chad, Chile, China, Colombia, Comoros, Congo, Costa Rica, Côte d’Ivoire, Croatia, Cuba, Cyprus, Czechia, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, North Korea, North Macedonia, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, São Tomé and Príncipe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Korea, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Sweden, Switzerland, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Türkiye, Turkmenistan, Tuvalu, Uganda, Ukraine, UAE, UK, USA, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Yemen, Zambia, Zimbabwe, Palestine, Vatican City